Cargando…

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis

INTRODUCTION: The GAP model was widely used as a simple risk “screening” method for patients with idiopathic pulmonary fibrosis (IPF). OBJECTIVES: We sought to validate the GAP model in Chinese patients with IPF to evaluate whether it can accurately predict the risk for mortality. METHODS: A total o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xinran, Ren, Yanhong, Xie, Bingbing, Wang, Shiyao, Geng, Jing, He, Xuan, Jiang, Dingyuan, He, Jiarui, Luo, Sa, Wang, Xin, Song, Dingyun, Fan, Mingming, Dai, Huaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500316/ https://www.ncbi.nlm.nih.gov/pubmed/36437511 http://dx.doi.org/10.1111/crj.13564

Ejemplares similares

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
por: Xie, Bingbing, et al.
Publicado: (2020)

Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis
por: Jiang, Dingyuan, et al.
Publicado: (2022)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Elastic Registration Algorithm Based on Three-dimensional Pulmonary MRI in Quantitative Assessment of Severity of Idiopathic Pulmonary Fibrosis
por: Yang, Xiaoyan, et al.
Publicado: (2023)

Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis
por: Geng, Jing, et al.
Publicado: (2015)

Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis
por: Geng, Jing, et al.
Publicado: (2022)

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway
por: Li, Zhen, et al.
Publicado: (2022)

A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
por: Fan, Mingming, et al.
Publicado: (2022)

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
por: Fan, Mingming, et al.
Publicado: (2023)

Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization
por: Fan, Mingming, et al.
Publicado: (2023)

Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease
por: Wei, Fengqin, et al.
Publicado: (2023)

IL‐17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cells
por: Xiao, Huijuan, et al.
Publicado: (2022)

Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
por: Jiang, Dingyuan, et al.
Publicado: (2016)

Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis
por: Song, Huifang, et al.
Publicado: (2019)

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis
por: Chandel, Abhimanyu, et al.
Publicado: (2023)

Feasibility and Mechanism Analysis of Shenfu Injection in the Treatment of Idiopathic Pulmonary Fibrosis
por: Liu, Peipei, et al.
Publicado: (2021)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
por: Yang, Shengnan, et al.
Publicado: (2021)

miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1
por: Li, Shuhong, et al.
Publicado: (2016)

Meta-Analysis of Genetic Programs between Idiopathic Pulmonary Fibrosis and Sarcoidosis
por: Leng, Dong, et al.
Publicado: (2013)

Clinical Manifestations, Genetic Variants and Therapeutic Evaluation in Sporadic Chinese Patients with Idiopathic Hypogonadotropic Hypogonadism
por: He, Dongye, et al.
Publicado: (2023)

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
por: Zhu, Lili, et al.
Publicado: (2022)

Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
por: Ryerson, Christopher J., et al.
Publicado: (2019)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians
por: Ni, Qi, et al.
Publicado: (2022)

The potential role of interleukin (IL)‐25/IL‐33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis
por: Xu, Xuefeng, et al.
Publicado: (2022)

The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity
por: Li, Fei, et al.
Publicado: (2020)

Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype
por: Zhang, Hui, et al.
Publicado: (2023)

Lung shrinking assessment on HRCT with elastic registration technique for monitoring idiopathic pulmonary fibrosis
por: Sun, Haishuang, et al.
Publicado: (2022)

Malignancies in Patients with Interstitial Lung Diseases: A Single Center Observational Study
por: Sun, Haishuang, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis disease progression: a dynamic quantitative chest computed tomography follow-up analysis
por: Sun, Haishuang, et al.
Publicado: (2023)

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
por: Ferrara, Giovanni, et al.
Publicado: (2018)

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
por: Huang, Hui, et al.
Publicado: (2015)

A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis
por: Jiang, Yale, et al.
Publicado: (2022)

Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routes
por: Yang, Shengnan, et al.
Publicado: (2022)

Three-dimensional ultrashort echo time magnetic resonance imaging in assessment of idiopathic pulmonary fibrosis, in comparison with high-resolution computed tomography
por: Yang, Xiaoyan, et al.
Publicado: (2022)

Epidemiological characteristics of pulmonary tuberculosis in patients with pneumoconiosis based on its social determinants and risk factors in China: a cross-sectional study from 27 provinces
por: Wang, Huanqiang, et al.
Publicado: (2022)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

A prognostic model based on clusters of molecules related to epithelial–mesenchymal transition for idiopathic pulmonary fibrosis
por: Zhao, Jiarui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ven05did8vq010pgh4d3s4g8nt